drugset / Trial / NCT04818099
Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy
Phase 3
Unknown
208 enrolled
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Affiliated Cancer Hospital & Institute of Guangzhou Medical University · collabBrain Hospital Affiliated to Guangzhou Medical University · collabSun Yat-sen University · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effects of vortioxetine, once daily (QD), on mood disorders and cognitive dysfunction in patients with head and neck cancers undergoing radiotherapy.
Timeline
- Start
- 2020-10-10
- Primary completion
- 2023-10-10
- Completion
- 2024-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vortioxetine | Unknown | 10 mg | — |